Sign in

CIK 0001754068

  • Non-accelerated filer
  • Smaller reporting company

Kalaris Therapeutics, Inc.

Sign in to watch
Ticker
KLRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831971007
Phone
+1 650-249-2727
Business address
400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
Former names
Allovir, Inc., ViraCyte, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 25 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-04-21 Atillasoy Ercem Sale −1,587 $5.86 $9K 121,563
2022-04-20 Sinha Vikas Director Sale −1,162 $6.68 $8K 906,633
2022-04-20 VAN BEEK JEROEN B Chief Commercial Officer Sale −852 $6.68 $6K 404,788
2022-04-20 Atillasoy Ercem Sale −453 $6.68 $3K 123,150
2022-04-20 Hagen Brett R Chief Accounting Officer Sale −276 $6.68 $2K 80,368
2022-03-29 Tomasello Shawn Director Grant or award · Stock Option (Right to Buy) +45,000 45,000
2022-03-11 Hallal David Director Sale −25,244 $7.37 $186K 2,147,841
2022-03-10 Hallal David Director Sale −40,481 $7.55 $306K 2,173,085
2022-03-02 VAN BEEK JEROEN B Chief Commercial Officer Sale −516 $9.01 $5K 382,384
2022-02-16 VAN BEEK JEROEN B Chief Commercial Officer Sale −15,322 $8.32 $128K 382,900
2022-02-10 Bornstein Jeffrey S Director Purchase +5,000 $8.87 $44K 35,197
2022-01-25 Atillasoy Ercem Sale −4,639 $8.24 $38K 100,347
2022-01-24 Hallal David Director Sale −17,100 $8.01 $137K 2,213,566
2022-01-20 VAN BEEK JEROEN B Chief Commercial Officer Sale −4,656 $8.75 $41K 398,222
2022-01-20 Hagen Brett R Chief Accounting Officer Sale −1,563 $8.75 $14K 63,202
2022-01-20 Sinha Vikas Director Sale −6,450 $8.75 $56K 858,957
2022-01-18 Leen Ann M. Chief Scientific Officer Grant or award +23,256 51,256
2022-01-18 Leen Ann M. Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +56,744 366,344
2022-01-18 Hagen Brett R Chief Accounting Officer Grant or award +17,442 80,644
2022-01-18 Hagen Brett R Chief Accounting Officer Grant or award · Stock Option (Right to Buy) +42,558 42,558

Page 15 of 27 · 527 trades